ASPIRA PATHLAB & DIAGNOSTICS
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹2.02 Cr | ₹-2.67 Cr |
| Adjustment | ₹1.78 Cr | ₹1.77 Cr |
| Changes In working Capital | ₹-1.97 Cr | ₹1.96 Cr |
| Cash Flow after changes in Working Capital | ₹1.83 Cr | ₹1.05 Cr |
| Cash Flow from Operating Activities | ₹1.83 Cr | ₹1.05 Cr |
| Cash Flow from Investing Activities | ₹0.12 Cr | ₹0.14 Cr |
| Cash Flow from Financing Activities | ₹-0.99 Cr | ₹-0.95 Cr |
| Net Cash Inflow / Outflow | ₹0.95 Cr | ₹0.24 Cr |
| Opening Cash & Cash Equivalents | ₹0.80 Cr | ₹0.57 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹1.75 Cr | ₹0.80 Cr |
Compare Cashflow Statement of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹134.9 Cr | NA | 6.1% | 126.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹132,139.0 Cr | 5% | 21.1% | 16.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹105,080.0 Cr | 6.9% | 32.7% | -7.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹67,959.9 Cr | 3.8% | 19.2% | 9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹62,284.1 Cr | 2.9% | 14% | -14.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,757.4 Cr | 2.7% | 14.9% | -7.6% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | NA |
6.1% |
126.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses